GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 2726 - 2750 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▼
IgM Patient 1 22 moderate
G58547FH
91
IgG Patient 2 15 mild
G09609EN
91
IgG Patient 2 15 mild
G17140UR
91
IgG Patient 2 24 mild
G17140UR
91
IgM Patient 2 15 mild
G07483YN
91
IgM Patient 2 3 mild
G68461PT
91
IgM Patient 3 -180 mild
G14844CX
91
IgM Patient 3 11 mild
G00054MO
91
IgG Patient 4 12 mild
G62826CL
91
IgG Patient 1 10 moderate
G39023AU
90
IgM Patient 1 10 moderate
G36544AC
90
IgM Patient 1 10 moderate
G81315DD
90
IgM Patient 1 10 moderate
G92022ML
90
IgG Patient 2 24 mild
G43648DB
90
IgG Patient 2 3 mild
G17140UR
90
IgG Patient 3 4 mild
G61399NC
90
IgG Patient 3 4 mild
G81315DD
90
IgM Patient 3 4 mild
G82942ZJ
90
IgG Patient 4 12 mild
G12200GB
90
IgG Patient 1 22 moderate
G62222PE
89
IgM Patient 1 22 moderate
G36191CD
89
IgG Patient 1 6 moderate
G39023AU
89
IgM Patient 3 -180 mild
G25407RZ
89
IgM Patient 3 -180 mild
G36544AC
89
IgM Patient 3 11 mild
G57449OF
89

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024